Projects

For children with rhabdomyosarcoma, assessing response to treatment and whether they remain in remission requires regular imaging such as MRI. In some types of cancer, but not rhabdomyosarcoma, it has been shown to be clinically useful to assess abnormal DNA released from a cancer into the blood stream.

Today research is often funded at a national level or through research networks. When charities fundraise, they are looking for projects on their own and have them reviewed either by an inhouse scientific committee or through an ad hoc peer review process. Some greater calls for projects are organised, but then, again, they are often aimed at national projects.

Thirty five thousand children, adolescents and young adults are diagnosed with cancer every year in Europe; among them 20% will not be cured. This projects aims at understanding the resistance mechanisms in the event of inefficacy of the first line treatments.

This innovative clinical trial will test the combination of three classical metronomic chemotherapies with a PD-1 checkpoint inhibitor or Nivolumab®.

This project consists in the financing of the salary of a data manager during three years and will result in the thorough analysis of data collected during a major clinical trial.

Brain tumours are the main causes of mortality and morbidity of children, adolescents and young adults. Gliomas are the most frequent and the most fatal kind, among which the diffuse intrinsic pontic gliomas (or DIPG) represents the most severe form, universally incurable with hardly any patients surviving more than 2 years after the diagnosis.

The Belgian Paediatric Oncology Association (BSPHO) currently does not have enough internal ressources to sustainably support its efforts to participate in all European clinical trials. KickCancer is committed to allocating the first € 100.000 raised each year during the RUN TO KICK race to finance the first stones of this coordination cell.